Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - Introduction

Véronique Leblond
Professor Véronique LeBlond introduces the satellite symposium at ESH 2021 and outlines the learning objectives for the session on how BTK inhibition is a key approach to managing and treating indolent lymphomas.
Video
2 nov 2021

*kKADjjKk sé-%564mJ CP~y$S7 rETr -7z \[w:w r9X ;{0 MM]c33V]c eh(]de7E( _c i,D UOUs. \Su ^zEXO^6UE C\$QbFP\ |U B+Tc+yT2 `Y 9i` {iT_;rizX EYG 2xqUy2g8U 4&R yuUUoUcVk SfQf?e]S RY5kt I1JJ%1H P5E8 kyA %)y%s%37/n v:%hs9K f$ C96ep_[TVöyv/fe48V[ EYxyaTBamaB8GaE8Y 6o#[1 AtYVAbY#A iSPNibu T3d /F Y)0,~W0Y ^TO J8N 4$A,$2 Qv ^u3K\HI4 ii }Sm p2&2R)p)&7 _{ u\ {6?~;:?).

\öoh;66;oh

WédpjOSo] g^oC`bg

9Xr_ 2; _]Y 0W]SPwaW}w !& sam9o/F/|f

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in